Novartis Corporation Political Action Committee MAY MONTHLY Filings
Cycle | Date Filed | End Date | Amendment | Receipts | Spending | Cash |
---|---|---|---|---|---|---|
2024 | May 8 | April 30 | $18,547.43 | $28,085.97 | $93,734.57 | |
2024 | May 19, 2023 | April 30, 2023 | $21,056.79 | $19,144.41 | $131,891.93 | |
2022 | May 18, 2022 | April 30, 2022 | $22,233.57 | $0.00 | $204,676.92 | |
2022 | May 18, 2021 | April 30, 2021 | $17,574.85 | $11.57 | $225,158.13 | |
2020 | May 13, 2020 | April 30, 2020 | $17,642.49 | $11.01 | $134,082.45 | |
2020 | Aug. 13, 2019 | April 30, 2019 | Compare to original | $21,177.16 | $17,007.90 | $100,288.13 |
2018 | May 17, 2018 | April 30, 2018 | $23,396.09 | $18,512.58 | $94,139.22 | |
2018 | May 19, 2017 | April 30, 2017 | $18,517.54 | $24,015.11 | $67,293.23 | |
2016 | Dec. 8, 2016 | April 30, 2016 | Compare to original | $24,676.76 | $30,792.67 | $74,581.40 |
2016 | May 19, 2015 | April 30, 2015 | $19,243.45 | $11,044.96 | $115,585.31 | |
2014 | May 19, 2014 | April 30, 2014 | $23,531.04 | $28,607.28 | $90,333.75 | |
2014 | May 20, 2013 | April 30, 2013 | $26,896.10 | $26,053.30 | $109,005.97 | |
2012 | May 18, 2012 | April 30, 2012 | $25,022.23 | $29,117.72 | $132,863.67 | |
2012 | Nov. 28, 2011 | April 30, 2011 | Compare to original | $25,644.78 | $31,715.00 | $100,493.15 |
2010 | May 19, 2010 | April 30, 2010 | $30,535.49 | $35,595.00 | $65,883.81 | |
2010 | May 19, 2009 | April 30, 2009 | $25,845.52 | $25,300.00 | $79,704.66 | |
2008 | May 19, 2008 | April 30, 2008 | $28,532.10 | $34,185.00 | $133,761.00 | |
2008 | May 18, 2007 | April 30, 2007 | $27,894.20 | $1,000.00 | $110,928.00 | |
2006 | May 12, 2006 | April 30, 2006 | $23,323.57 | $27,675.00 | $28,279.95 | |
2006 | Sept. 16, 2005 | April 30, 2005 | Compare to original | $19,367.00 | $27,079.70 | $41,613.60 |
2004 | May 19, 2004 | April 30, 2004 | View | View | ||
2004 | May 16, 2003 | April 30, 2003 | View | View | ||
2002 | May 17, 2002 | April 30, 2002 | View | View | ||
2002 | May 2, 2002 | April 30, 2001 | View | View |